Angel Yeast announced that the company's second extraordinary shareholders' meeting in 2026 reviewed and passed the “Proposal on the Enzyme Formulation Company's New Synthetic Biology Pilot Verification Base Project”. A total of 799 shareholders and agents attended the meeting. The total number of voting shares held was 464 million, accounting for 53.44% of the company's total voting shares. The conference calling, holding and voting procedures complied with relevant regulations, and Beijing Commerce Law Firm witnessed and issued legal and effective opinions.

Angel Yeast announced that the company's second extraordinary shareholders' meeting in 2026 reviewed and passed the “Proposal on the Enzyme Formulation Company's New Synthetic Biology Pilot Verification Base Project”. A total of 799 shareholders and agents attended the meeting. The total number of voting shares held was 464 million, accounting for 53.44% of the company's total voting shares. The conference calling, holding and voting procedures complied with relevant regulations, and Beijing Commerce Law Firm witnessed and issued legal and effective opinions.